Hepatocyte-targeting Gene Transfer Mediated by Galactosylated Poly(ethylene Glycol)-graft-polyethylenimine Derivative
Overview
Affiliations
Biscarbamate cross-linked polyethylenimine derivative (PEI-Et) has been reported as a novel nonviral vector for efficient and safe gene transfer in our previous work. However, it had no cell-specificity. To achieve specific delivery of genes to hepatocytes, galactosylated poly(ethylene glycol)-graft-polyethylenimine derivative (GPE) was prepared through modification of PEI-Et with poly(ethylene glycol) and lactobionic acid, bearing a galactose group as a hepatocyte-targeting moiety. The composition of GPE was characterized by proton nuclear magnetic resonance. The weight-average molecular weight of GPE measured with a gel permeation chromatography instrument was 9489 Da, with a polydispersity of 1.44. GPE could effectively condense plasmid DNA (pDNA) into nanoparticles. Gel retardation assay showed that GPE/pDNA complexes were completely formed at weigh ratios (w/w) over 3. The particle size of GPE/pDNA complexes was 79-100 nm and zeta potential was 6-15 mV, values which were appropriate for cellular uptake. The morphology of GPE/pDNA complexes under atomic force microscopy appeared spherical and uniform in size, with diameters of 53-65 nm. GPE displayed much higher transfection efficiency than commercially available PEI 25 kDa in BRL-3A cell lines. Importantly, GPE showed good hepatocyte specificity. Also, the polymer exhibited significantly lower cytotoxicity compared to PEI 25 kDa at the same concentration or weight ratio in BRL-3A cell lines. To sum up, our results indicated that GPE might carry great potential in safe and efficient hepatocyte-targeting gene delivery.
Preparation and Characterization of a Liver Targeted, Poly(amidoamine) Based, Gene Delivery System.
Ebeid K, Geary S, Salem A Methods Mol Biol. 2022; 2455:319-332.
PMID: 35213004 PMC: 9670859. DOI: 10.1007/978-1-0716-2128-8_24.
Cao M, Gao Y, Zhan M, Qiu N, Piao Y, Zhou Z Int J Mol Sci. 2019; 20(20).
PMID: 31614879 PMC: 6829341. DOI: 10.3390/ijms20205074.
Wang Y, Zhao D, Wei X, Ma L, Sheng J, Lu P Biomed Res Int. 2019; 2019:8483765.
PMID: 31467913 PMC: 6699321. DOI: 10.1155/2019/8483765.
Drug Delivery Strategies for Antivirals against Hepatitis B Virus.
Singh L, Indermun S, Govender M, Kumar P, du Toit L, Choonara Y Viruses. 2018; 10(5).
PMID: 29772748 PMC: 5977260. DOI: 10.3390/v10050267.
Rajasekaran D, Srivastava J, Ebeid K, Gredler R, Akiel M, Jariwala N Bioconjug Chem. 2015; 26(8):1651-61.
PMID: 26079152 PMC: 4783168. DOI: 10.1021/acs.bioconjchem.5b00254.